Poland· PL-100490129
Jaypirca
A medicinal product containing pirtobrutinibum, registered in Poland by Eli Lilly Nederland B.V..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Pirtobrutinibum
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05999885490226
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pirtobrutinibum in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJAYPIRCAEli Lilly Nederland B.V., Utrecht
- SwitzerlandJaypirca
- FinlandJaypircaEli Lilly Nederland B.V
- FranceJAYPIRCA 100 mg, comprimé pelliculéELI LILLY NEDERLAND BV (PAY-BAS)
- IrelandJaypirca 100 mg film-coated tabletsEli Lilly Nederland B.V.
- IcelandJaypircaEli Lilly Nederland B.V.*
- NetherlandsJaypirca 100 mg filmomhulde tablettenEli Lilly Nederland B.V.
- NorwayJaypircaEli Lilly Nederland B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Jaypirca
- Liechtenstein · Jaypirca
- Norway · Jaypirca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0cf6985a-b8c0-44df-92da-921fa9ece70b GET /v1/drugs/0cf6985a-b8c0-44df-92da-921fa9ece70b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg",
"packaging": "Rpz ¦ EU/1/23/1738/005 ¦ 152098\n30 tabl.\n05999885490226 ¦ Rpz ¦ EU/1/23/1738/004 ¦ 152099\n28 tabl.\nRpz ¦ EU/1/23/1738/008 ¦ 152100\n84 tabl.\nRpz ¦ EU/1/23/1738/006 ¦ 152101\n56 tabl.\nRpz ¦ EU/1/23/1738/007 ¦ 152102\n60 tabl.\nRpz ¦ EU/1/23/1738/009 ¦ 152103\n168 tabl.",
"substance": "Pirtobrutinibum 100 mg",
"common_name": "Pirtobrutinibum",
"pl_product_id": "100490129",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about pirtobrutinibum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.